PL387312A1 - Zastosowanie sulindaku i/lub jego metabolitu we wspomagającym leczeniu raka jelita grubego u ludzi - Google Patents

Zastosowanie sulindaku i/lub jego metabolitu we wspomagającym leczeniu raka jelita grubego u ludzi

Info

Publication number
PL387312A1
PL387312A1 PL387312A PL38731209A PL387312A1 PL 387312 A1 PL387312 A1 PL 387312A1 PL 387312 A PL387312 A PL 387312A PL 38731209 A PL38731209 A PL 38731209A PL 387312 A1 PL387312 A1 PL 387312A1
Authority
PL
Poland
Prior art keywords
sulindac
metabolite
humans
colorectal cancer
adjunctive treatment
Prior art date
Application number
PL387312A
Other languages
English (en)
Inventor
Jacek Spławiński
Sylwia Flis
Original Assignee
Farma-Projekt Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farma-Projekt Spółka Z Ograniczoną Odpowiedzialnością filed Critical Farma-Projekt Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL387312A priority Critical patent/PL387312A1/pl
Priority to PCT/PL2010/000015 priority patent/WO2010095965A1/en
Publication of PL387312A1 publication Critical patent/PL387312A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL387312A 2009-02-19 2009-02-19 Zastosowanie sulindaku i/lub jego metabolitu we wspomagającym leczeniu raka jelita grubego u ludzi PL387312A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL387312A PL387312A1 (pl) 2009-02-19 2009-02-19 Zastosowanie sulindaku i/lub jego metabolitu we wspomagającym leczeniu raka jelita grubego u ludzi
PCT/PL2010/000015 WO2010095965A1 (en) 2009-02-19 2010-02-18 The use of sulindac and/or its metabolite as adjuvant treatment for colon cancer in humans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL387312A PL387312A1 (pl) 2009-02-19 2009-02-19 Zastosowanie sulindaku i/lub jego metabolitu we wspomagającym leczeniu raka jelita grubego u ludzi

Publications (1)

Publication Number Publication Date
PL387312A1 true PL387312A1 (pl) 2010-08-30

Family

ID=42122923

Family Applications (1)

Application Number Title Priority Date Filing Date
PL387312A PL387312A1 (pl) 2009-02-19 2009-02-19 Zastosowanie sulindaku i/lub jego metabolitu we wspomagającym leczeniu raka jelita grubego u ludzi

Country Status (2)

Country Link
PL (1) PL387312A1 (pl)
WO (1) WO2010095965A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2478407C1 (ru) * 2011-09-05 2013-04-10 Федеральное государственное бюджетное учреждение Министерства здравоохранения и социального развития Российской Федерации "Медицинский радиологический научный центр" (ФГБУ МРНЦ Минздравсоцразвития России) Способ комбинированного лечения местно-распространенного рака желудка
SG10202104160TA (en) * 2016-11-11 2021-06-29 Cellix Bio Private Ltd Compositions and methods for the treatment of gastrointestinal polyps
RU2725079C2 (ru) * 2020-02-25 2020-06-29 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) Способ комбинированного лечения местно-распространенного рака желудка
RU2765845C1 (ru) * 2021-02-24 2022-02-03 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ комбинированного лечения местнораспространённого кардиоэзофагельного рака

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1202746T3 (da) * 1999-08-12 2007-01-02 Wyeth Corp NSAID- og EGFR-kinaseinhibitorerholdigt præparat til behandling eller inhibering af colonpolypper og colorektal cancer
JP2003514017A (ja) * 1999-11-15 2003-04-15 アドバンスト リサーチ アンド テクノロジー インスティテュート，インコーポレイティド 膵臓癌の治療のためのｎｓａｉｄの使用
EP1428528A1 (en) 2002-09-27 2004-06-16 Tiense Suikerraffinaderij N.V. Synergistic combinations of dietary fiber and NSAIDs for the treatment of cancer
JP2005247807A (ja) * 2004-03-08 2005-09-15 Japan Science & Technology Agency Ｎｓａｉｄを利用した癌治療用組成物
US8765808B2 (en) 2005-03-23 2014-07-01 Chs Pharma, Inc. Treatment or prevention of cancer and precancerous disorders
ITMI20051107A1 (it) 2005-06-14 2005-09-13 Ctg Pharma S R L Metodo per il trattamento del cancro

Also Published As

Publication number Publication date
WO2010095965A1 (en) 2010-08-26

Similar Documents

Publication Publication Date Title
DK2483278T3 (da) Benzoxazepin pi3k-inhibitorforbindelser og deres anvendelse i behandlingen af cancer
SMT201600430B (it) Inibitori di chinasi e loro uso nel trattamento del cancro
EP2467093A4 (en) JOINT DEPLOYMENT DEVICE AND METHOD OF USE
BRPI0916269A2 (pt) dispositivo de modificação de tecido e seu método de uso
HRP20180660T1 (hr) Sustavi i postupci za liječenje tkiva prostate
PL2657253T3 (pl) Przeciwciała anty-CD79b i immunokoniugaty i sposoby stosowania
PL2474557T3 (pl) Przeciwciała anty- CD79b i immunokoniugaty i sposoby stosowania
PL2881402T3 (pl) Ekspresja zmutowanej ROS w ludzkim raku wątroby
BR112012018329A2 (pt) agentes de coloração e métodos de uso destes
BRPI1012333A2 (pt) atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso
DK2231091T3 (da) Absorber og absorberende engangsartikel
PT2252283T (pt) Triterpenóides sintéticos e métodos de uso no tratamento de doença
BRPI0919150A2 (pt) aplicadores de fluxo de ar e métodos de tratamento relacionados
DK2235002T3 (da) 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer
ZA201003625B (en) 5-anilinoimidazopyridines and methods of use
LT3778885T (lt) Dirbtinai sukurtų žmogaus arginazių kompozicijos ir vėžio gydymo metodai
PL3095447T3 (pl) Leczenie niedoboru lub deficytu witaminy d 25-hydroksywitaminą d2 i 25- hydroksywitaminą d3
FI20075881A0 (fi) Lääketieteellinen väline ja sen käyttö
PL2632452T3 (pl) Związki i kompozycje stosowane w leczeniu nowotworów
BRPI0922344A2 (pt) inibidores de tfpi e métodos de uso
IL206125A0 (en) Azaindolizines and methods of use
ES1066168Y (es) Dispositivo de guia para muebles y similares
BRPI0916694A2 (pt) combinação antineoplásicas de 4-anilino-3-cianoquinolinas e capecitabina
DK2536748T3 (da) Neuregulin-antagonister og anvendelse deraf ved behandling af kræft
PL2549995T3 (pl) Zastosowanie anatabiny w leczeniu stanów zapalnych i metody syntezy anatabiny

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)